Evotec SE Valuation
| EVOTF Stock | USD 6.77 0.00 0.00% |
At this time, the firm appears to be fairly valued. Evotec SE shows a prevailing Real Value of $6.85 per share. The current price of the firm is $6.77. Our model computes the value of Evotec SE from reviewing the firm fundamentals such as Shares Outstanding of 176.95 M, current valuation of 2.68 B, and Profit Margin of (0.26) % as well as analyzing its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Evotec SE's price fluctuation is very steady at this time. Calculation of the real value of Evotec SE is based on 3 months time horizon. Increasing Evotec SE's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Evotec pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Evotec SE. Since Evotec SE is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Evotec Pink Sheet. However, Evotec SE's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.77 | Real 6.85 | Hype 6.77 | Naive 6.78 |
The real value of Evotec Pink Sheet, also known as its intrinsic value, is the underlying worth of Evotec SE Company, which is reflected in its stock price. It is based on Evotec SE's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Evotec SE's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Evotec SE helps investors to forecast how Evotec pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Evotec SE more accurately as focusing exclusively on Evotec SE's fundamentals will not take into account other important factors: Evotec SE Total Value Analysis
Evotec SE is currently anticipated to have takeover price of 2.68 B with market capitalization of 4.14 B, debt of 326.34 M, and cash on hands of 887.88 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Evotec SE fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.68 B | 4.14 B | 326.34 M | 887.88 M |
Evotec SE Investor Information
About 66.0% of the company shares are held by institutions such as insurance companies. The book value of Evotec SE was currently reported as 6.95. The company has Price/Earnings (P/E) ratio of 347.66. Evotec SE had not issued any dividends in recent years. The entity had 50:1 split on the 3rd of June 1999. Based on the measurements of operating efficiency obtained from Evotec SE's historical financial statements, Evotec SE is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Evotec SE Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Evotec implies not a very effective usage of assets in November.Evotec SE Ownership Allocation
Evotec SE holds a total of 176.95 Million outstanding shares. Over half of Evotec SE's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that obtain positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Evotec SE Profitability Analysis
The company reported the revenue of 618.03 M. Net Income was 215.51 M with profit before overhead, payroll, taxes, and interest of 151.54 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Evotec SE's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Evotec SE and how it compares across the competition.
About Evotec SE Valuation
The pink sheet valuation mechanism determines Evotec SE's current worth on a weekly basis. Our valuation model uses a comparative analysis of Evotec SE. We calculate exposure to Evotec SE's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Evotec SE's related companies.Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. Evotec SE was incorporated in 1993 and is headquartered in Hamburg, Germany. EVOTEC SE operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4521 people.
8 Steps to conduct Evotec SE's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Evotec SE's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Evotec SE's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Evotec SE's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Evotec SE's revenue streams: Identify Evotec SE's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Evotec SE's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Evotec SE's growth potential: Evaluate Evotec SE's management, business model, and growth potential.
- Determine Evotec SE's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Evotec SE's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Evotec SE Growth Indicators
Investing in growth stocks can be very risky. If the company such as Evotec SE does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 173.9 M | |
| Quarterly Earnings Growth Y O Y | 1.909 | |
| Forward Price Earnings | 79.3651 | |
| Retained Earnings | -216.4 M |
Complementary Tools for Evotec Pink Sheet analysis
When running Evotec SE's price analysis, check to measure Evotec SE's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evotec SE is operating at the current time. Most of Evotec SE's value examination focuses on studying past and present price action to predict the probability of Evotec SE's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evotec SE's price. Additionally, you may evaluate how the addition of Evotec SE to your portfolios can decrease your overall portfolio volatility.
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |